[Federal Register Volume 74, Number 186 (Monday, September 28, 2009)]
[Notices]
[Pages 49383-49384]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-23269]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel. Pharmacodynamic Assays for Cancer Therapeutics.
    Date: October 6, 2009.
    Time: 11 a.m. to 1:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room  210, Rockville, MD 20852. (Telephone Conference 
Call).
    Contact Person: Thomas M Vollberg, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 7142, Bethesda, MD 20892. 301-594-9582. [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to scheduling conflicts.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel. R13 Conference Grants Review.
    Date: October 29, 2009.
    Time: 1 p.m. to 5 p.m.

[[Page 49384]]

    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
8041, Rockville, MD 20852. (Telephone Conference Call).
    Contact Person: Bratin K. Saha, PhD, Scientific Review Officer, 
Program Coordination and Referral Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8041, Bethesda, MD 20892. (301) 402-0371. 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel. NCI Cancer Prevention Research II.
    Date: October 30, 2009.
    Time: 10 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room  210, Rockville, MD 20852. (Telephone Conference 
Call).
    Contact Person: Irina Gordienko, PhD, Scientific Review Officer, 
Scientific Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., 
Rm. 7073, Bethesda, MD 20892. 301-594-1566. 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel. Community Clinical Oncology Programs.
    Date: December 1-2, 2009.
    Time: 7 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Courtyard Gaithersburg Washingtonian Ctr, 204 
Boardwalk Place, Gaithersburg, MD 20878.
    Contact Person: Gerald G. Lovinger, PhD, Scientific Review 
Administrator, Special Review and Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Blvd., Room 8101, Bethesda, MD 20892-8329. 301/496-7987. 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: September 21, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-23269 Filed 9-25-09; 8:45 am]
BILLING CODE 4140-01-P